A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuary.
Skanji R, Andrieux K, Lalanne M, Caron J, Bourgaux C, Degrouard J, Brisset F, Gueutin C, Chacun H, Dereuddre-Bosquet N, Paci A, Vassal G, Bauduin L, Garcia-Argote S, Rousseau B, Clayette P, Desmaële D, Couvreur P.
Skanji R, et al. Among authors: chacun h.
Int J Pharm. 2011 Jul 29;414(1-2):285-97. doi: 10.1016/j.ijpharm.2011.05.005. Epub 2011 May 10.
Int J Pharm. 2011.
PMID: 21596125